CRANAD-28

• Description:

  CRANAD-28 is a robust fluorescent compound for visualization of amyloid beta plaques[1].

• UNSPSC:

  12171500

• Hazard Statement:

  H315-H319

• Target:

  Fluorescent Dye

• Type:

  Dye Reagents

• Related Pathways:

  Others

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/cranad-28.html

• Purity:

  98.03

• Solubility:

  DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)

• Smiles:

  CC(N(C1=CC=CC=C1)N=C2)=C2/C=C/C([CH-]C(/C=C/C(C=NN3C4=CC=CC=C4)=C3C)=[O]5)=[O][B+3]5([F-])[F-]

• Molecular Formula:

  C27H23BF2N4O2

• Molecular Weight:

  484.30

• Precautions:

  P264-P280-P302+P352-P305+P351+P338-P362+P364

• References & Citations:

  [1]Kathleen Ran, et al. CRANAD-28: A Robust Fluorescent Compound for Visualization of Amyloid Beta Plaques. Molecules. 2020 Feb 16;25 (4) :863.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category:

  Dye Reagents

• Clinical Information:

  No Development Reported

• CAS Number:

  [1623747-97-6]